Mammoth Biosciences Thinks Ultra-Small As It Attains Elephant-Sized Valuation

 
• By Alaric DeArment

The Jennifer Doudna-backed startup got a billion-dollar valuation with VC rounds totaling $195m. CEO Trevor Martin talked with Scrip about Mammoth’s ultra-small CRISPR system technology.

Venture Capital Concept on the Mechanism of Metal Gears.
Mammoth Biosciences has attained unicorn status with series C and D fund raises totalling $195m • Source: Shutterstock

More from Financing

More from Business